News Releases
Metacrine Completes $65 Million Series C Financing
Proceeds will support clinical development of FXR program in NASH and GI diseases SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today announced it has
Jun 6, 2018
Metacrine to Present at Jefferies 2018 Global Healthcare Conference
SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today announced that Ken Song, M.D., President and CEO, will present at the Jefferies 2018 Global Healthcare
May 31, 2018
Metacrine Broadens Management Team with Two Key Hires
SAN DIEGO, April 17, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today announced two new key management appointments. Trisha M.
Apr 17, 2018
Displaying 31 - 40 of 44